B
69.69
0.33 (0.48%)
| Previous Close | 69.36 |
| Open | 69.59 |
| Volume | 2,778,700 |
| Avg. Volume (3M) | 2,589,131 |
| Market Cap | 13,441,956,864 |
| Price / Sales | 23.15 |
| 52 Weeks Range | |
| Earnings Date | 4 Aug 2026 |
| Operating Margin (TTM) | -89.00% |
| Diluted EPS (TTM) | -3.56 |
| Quarterly Revenue Growth (YOY) | -44.80% |
| Current Ratio (MRQ) | 4.57 |
| Operating Cash Flow (TTM) | -500.42 M |
| Levered Free Cash Flow (TTM) | -261.20 M |
| Return on Assets (TTM) | -48.27% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Bullish | Mixed |
| Biotechnology (Global) | Bullish | Mixed | |
| Stock | BridgeBio Pharma, Inc. | Bullish | Bullish |
AIStockmoo Score
1.4
| Analyst Consensus | 2.0 |
| Insider Activity | -4.0 |
| Price Volatility | 1.0 |
| Technical Moving Averages | 5.0 |
| Technical Oscillators | 3.0 |
| Average | 1.40 |
|
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Growth |
| % Held by Insiders | 4.97% |
| % Held by Institutions | 98.14% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Aisling Capital Management Lp | 31 Mar 2026 | 5,089,611 |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| AGUIAR ERIC | 68.92 | - | 3,990 | 274,991 |
| COOK JENNIFER E. | 68.92 | 68.66 | -125,613 | -8,589,944 |
| DACHILLE DOUGLAS A. | 68.92 | - | 3,990 | 274,991 |
| DANIELS RONALD J | 68.92 | - | 3,990 | 274,991 |
| ELLIS ANDREA | 68.92 | - | 3,990 | 274,991 |
| HASSAN FRED | 68.92 | - | 3,990 | 274,991 |
| HOMCY CHARLES J | 68.92 | 66.27 | 3,202 | 222,770 |
| LO ANDREW | 68.92 | - | 3,990 | 274,991 |
| MCCORMICK FRANK | 68.92 | - | 3,990 | 274,991 |
| MOMTAZEE JAMES C | 68.92 | - | 3,990 | 274,991 |
| SATVAT ALI J. | 68.92 | - | 3,990 | 274,991 |
| VALANTINE HANNAH | 68.92 | 68.78 | -1,014 | -69,248 |
| Aggregate Net Quantity | -87,515 | |||
| Aggregate Net Value ($) | -5,961,505 | |||
| Aggregate Avg. Buy ($) | 68.92 | |||
| Aggregate Avg. Sell ($) | 68.30 | |||
| Insider Range ($) | ||||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| COOK JENNIFER E. | Director | 24 Jun 2026 | Automatic sell (-) | 37,167 | 69.36 | 2,577,903 |
| COOK JENNIFER E. | Director | 24 Jun 2026 | Option execute | 37,167 | - | - |
| VALANTINE HANNAH | Director | 23 Jun 2026 | Automatic sell (-) | 2,196 | 68.63 | 150,711 |
| COOK JENNIFER E. | Director | 23 Jun 2026 | Automatic sell (-) | 2,196 | 68.63 | 150,711 |
| DACHILLE DOUGLAS A. | Director | 22 Jun 2026 | Acquired (+) | 3,990 | 68.92 | 274,991 |
| SATVAT ALI J. | Director | 22 Jun 2026 | Acquired (+) | 3,990 | 68.92 | 274,991 |
| MCCORMICK FRANK | Director | 22 Jun 2026 | Acquired (+) | 3,990 | 68.92 | 274,991 |
| MOMTAZEE JAMES C | Director | 22 Jun 2026 | Acquired (+) | 3,990 | 68.92 | 274,991 |
| HASSAN FRED | Director | 22 Jun 2026 | Acquired (+) | 3,990 | 68.92 | 274,991 |
| ELLIS ANDREA | Director | 22 Jun 2026 | Acquired (+) | 3,990 | 68.92 | 274,991 |
| DANIELS RONALD J | Director | 22 Jun 2026 | Acquired (+) | 3,990 | 68.92 | 274,991 |
| AGUIAR ERIC | Director | 22 Jun 2026 | Acquired (+) | 3,990 | 68.92 | 274,991 |
| HOMCY CHARLES J | Director | 22 Jun 2026 | Acquired (+) | 3,990 | 68.92 | 274,991 |
| VALANTINE HANNAH | Director | 22 Jun 2026 | Acquired (+) | 3,990 | 68.92 | 274,991 |
| VALANTINE HANNAH | Director | 22 Jun 2026 | Automatic sell (-) | 2,808 | 68.92 | 193,527 |
| VALANTINE HANNAH | Director | 22 Jun 2026 | Option execute | 2,808 | - | - |
| LO ANDREW | Director | 22 Jun 2026 | Acquired (+) | 3,990 | 68.92 | 274,991 |
| COOK JENNIFER E. | Director | 22 Jun 2026 | Acquired (+) | 3,990 | 68.92 | 274,991 |
| HOMCY CHARLES J | Director | 20 Jun 2026 | Disposed (-) | 788 | 66.27 | 52,221 |
| COOK JENNIFER E. | Director | 15 Jun 2026 | Automatic sell (-) | 90,240 | 68.00 | 6,136,320 |
| COOK JENNIFER E. | Director | 15 Jun 2026 | Option execute | 83,088 | - | - |
| Show more | ||||||
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |